Jane Street
RPRX icon

Jane Street’s Royalty Pharma RPRX Stock Holding History

Jane Street’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.85M Sell
122,100
-55,600
-31% -$2.89M ﹤0.01% 3288
2026
Q1 		$8.52M Buy
177,700
+121,800
+218% +$5.33M ﹤0.01% 2742
2025
Q4 		$2.16M Buy
+55,900
New +$2.13M ﹤0.01% 4673
2025
Q3 		– Sell
-63,300
Closed -$2.28M – 11621
2025
Q2 		$2.28M Buy
63,300
+56,700
+859% +$1.88M ﹤0.01% 4216
2025
Q1 		$205K Buy
+6,600
New +$209K ﹤0.01% 8408
2024
Q2 		– Sell
-27,200
Closed -$826K – 10076
2024
Q1 		$826K Sell
27,200
-5,800
-18% -$171K ﹤0.01% 5749
2023
Q4 		$927K Sell
33,000
-2,700
-8% -$74.2K ﹤0.01% 5696
2023
Q3 		$969K Buy
+35,700
New +$1.06M ﹤0.01% 5228
2023
Q1 		– Sell
-29,500
Closed -$1.17M – 9790
2022
Q4 		$1.17M Sell
29,500
-7,300
-20% -$305K ﹤0.01% 4745
2022
Q3 		$1.48M Buy
36,800
+14,700
+67% +$628K ﹤0.01% 4707
2022
Q2 		$929K Sell
22,100
-2,500
-10% -$102K ﹤0.01% 5618
2022
Q1 		$958K Sell
24,600
-69,100
-74% -$2.71M ﹤0.01% 6222
2021
Q4 		$3.73M Sell
93,700
-26,900
-22% -$1.05M ﹤0.01% 3321
2021
Q3 		$4.36M Buy
120,600
+110,700
+1,118% +$4.3M ﹤0.01% 2968
2021
Q2 		$406K Buy
9,900
+2,300
+30% +$97.8K ﹤0.01% 7635
2021
Q1 		$332K Buy
+7,600
New +$360K ﹤0.01% 7530

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's RPRX Position: Q2 2026 in Review

Jane Street reduced its Royalty Pharma (RPRX) stake by 98% in Q2 2026, selling an estimated $122M and leaving 53,460 shares worth $3M. The position accounts for ﹤0.01% of the portfolio, ranked #4512.

Jane Street first reported a position in RPRX in Q2 2020 and has held it in 24 quarters since. The position peaked at $191M in Q4 2025. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Jane Street held 53,460 shares of Royalty Pharma worth $3M as of Q2 2026.
  • Jane Street sold 2,346,922 Royalty Pharma shares in Q2 2026, an estimated $122M.
  • Royalty Pharma made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4512 holding.
  • Jane Street first reported a position in Royalty Pharma in Q2 2020 and has held it in 24 quarters since.
  • Jane Street's Royalty Pharma position peaked at $191M in Q4 2025.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.